Neuroscience

Answering the question 'Will I get better?'

Speech pathologists lack a consistent approach to communicating post-stroke recovery information to patients, a University of Queensland study has found.

Oncology & Cancer

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Oncology & Cancer

B cells linked to effective cancer immunotherapy

Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumors contained specific clusters of B cells, according to new research from Lund University in Sweden. The study is published ...

Oncology & Cancer

Researchers leverage cell self-destruction to treat brain tumors

Glioblastoma is the most common type of brain tumor in adults. The disease is 100% fatal and there are no cures, making it the most aggressive type of cancer. Such a poor prognosis has motivated researchers and neurosurgeons ...

page 2 from 13